Antares Pharma Reports EPS of $(0.02) vs. $(0.02)

Antares Pharma, Inc. AIS today reported financial and operating results for the fourth quarter ended December 31, 2010.

Total revenue was $3.3 million and $12.8 million for the three months and year ended December 31, 2010

Net loss per share decreased to $0.02 for the fourth quarter of 2010 from $0.03 in 2009.